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Abstract 
A new class of pyrazolo[3,4-a]acridines have been prepared, the synthon acridones were 
obtained in very good yield by one pot reaction of 2-amino-5-chloro or nitro substituted 
benzophenones with 1,3-cyclic diketones in the presence of freshly prepared Eaton’s 
reagent without solvent, using Friedländer synthesis. The intermediates were reacted with 
ethylformate followed by hydrazine hydrate to afford pyrazolo[3,4-a]acridines. All of the 
compounds were purified by recrystallization only, and no chromatographic work-up was 
required. The structures of the synthesized compounds were deduced by spectroscopic 
techniques, including single crystal X-ray diffraction. 
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KEYWORDS: Eaton’s reagent, Friedländer synthesis, ethylformate, hydrazine hydrate, 
pyrazolo[3,4-a]acridines 
 
INTRODUCTION 
Heterocyclic compounds, featuring an acridine scaffold, exhibit a wide variety of 
biological properties and functions and are of interest in organic chemistry. Acridine 
derivatives (ADs), known since the 19
th
 century, where first used as pigments and dyes
[1]
 
and have been used for commercial purposes for more than a century. Several naturally 
occurring as well as synthetic ADs are known for antitumor,
[2]
 antioxidant,
[3]
 
anticancer,
[4]
 antimicrobial and antiparasitic activities. The acridine nucleus, condensed 
with additional heterocyclic rings, is also endowed with high cytotoxicity. Specifically, 
incorporation of five membered heterocyclic rings into the acridine chromophore strongly 
favors passive cellular drug uptake, rendering the efflux by MDR transporters 
inefficient.
[5]
 The pyrazole nucleus is of interest for the development of new drugs, 
because of synthetic accessibility and diverse chemical and biological properties such as 
fungicidal, antimicrobial, anti-parasitic, anti-inflammatory, anticancer and antiviral 
activities.
[6]
 Some pyrazoloacridine derivatives are known to fragment DNA through 
intercalation, causing apoptosis.
[7]
 Within the pyrazoloacridine family, pyrazolo[3,4,5,-
kl]acridine (PZA, I) (Figure. 1) type of compounds containing electron deactivating nitro 
group proved to be a very exciting new class of antitumor agents, PZA is currently 
undergoing phase II clinical trials after exhibiting a broad spectrum of antitumor 
activities in preclinical in-vivo assays.[7,8] PZA displays solid tumor selectivity, activity 
against hypoxic cells and cytotoxicity in noncycling cells.
[9]
 In addition, 4,5-
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dihydropyrazolo[3,4-a]acridines were recently found to function as acetyl cholinesterase 
inhibitors.
[10] 
 
A well-known method for obtaining quinolines and related poly heterocycles involves the 
Friedländer quinoline synthesis. Known for more than a century, Friedländer synthesis
[11]
 
was applied to prepare quinoline derivatives by condensation of 2-aminoarylketones with 
carbonyl compounds possessing a reactive methylene group, followed by 
cyclodehydration
[12]
. Although considered the most useful method for the preparation of 
such a class of compounds, the synthetic protocols for polycyclic quinolines reported so 
far lead to low yields, extended reaction times, and dependence on harmful and often 
expensive catalyst systems, making the development of a simple, eco-friendly, low cost 
protocol desirable. We recently reported
[13]
 cyclic imide synthesis using Eaton’s 
reagent
[14]
 (Phosphorus pentoxide-methanesulfonic acid) through cyclisation with 
Hydrazinylquinolines and cyclic anhydrides and successfully employed the Friedlander 
method on polycyclic quinolines by using Eaton’sreagent. 
 
Here we wish to report a practical and easy workup method for the synthesis of poly 
substituted quinolines using Eaton’s reagent as alternative to Polyphosphoric acid (PPA) 
under solvent free conditions. 
 
The reaction of 2-amino-5-nitrobenzophenone (1a) and 1,3-cyclohexanedione (2a) in the 
presence of freshly prepared Eaton’s reagent (Phosphorus pentoxide-methanesulfonic 
acid) as a catalyst without solvent at 90ºC afforded 3a in 89% yield (Scheme 1). The IR 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
ris
tol
] a
t 0
0:2
8 2
3 J
uly
 20
15
 
  4 
spectrum for 3a shows an absorption band at 1694 cm
-1
 due to the presence of the C=O 
group and a sharp band at1552cm
-1
confirmed the presence of the C=N group. The
1
H 
NMR (CDCl3, 400 MHz) spectrum for 3a shows a multiplet at δ 2.187-2.251 due to the 
C3-CH2 protons, a multiplet at δ 2.665-2.698 due to the C2-CH2 protons, and a multiplet 
at δ 3.334-3.366 due to the C4-CH2 protons. The remaining aromatic protons appeared in 
the region of δ 7.109-8.435. The13C NMR (CDCl3, 100 MHz) spectrum of 3a shows the 
presence of 19 carbon signals. 
 
In demonstrating efficiency and scope of Eaton’s reagent for the synthesis of quinolines, 
cyclic ketones such as 1,3-cyclohexanedione and 5,5-dimethyl-1,3-cyclohexanedione 
smoothly condensed with 2-aminoaryl ketones to afford the respective polycyclic 
quinolines (Scheme 2). In most cases, the products were isolated by simple filtration and 
the crude products were purified by recrystallization from a mixture of ethylacetate and 
acetonitrile. All compounds (Table. 1) were isolated by recrystallization only and no 
chromatographic work-up was required to obtain pure products. The structures of 3a, 3c, 
and 3f were confirmed by single crystal X-ray diffraction (Figure.2, 3, & 4). 
 
Pyrazolo[3,4-a]acridines were synthesized from precursor polycyclic quinolones (3) and 
ethylformate. Sodium methoxide initiated the reaction, which took 4-5h at room 
temperature yielding exclusively (4), confirmed by TLC analysis (Scheme 3). After 
completion of the reaction, quenching with water dissolved the excess of sodium 
methoxide. Further purification via column chromatography was found to be unnecessary 
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(Table. 2). The structures of the derivatives 4a and 4b were confirmed by single crystal 
X-ray diffraction (Fig.5 & 6). 
 
2-(hydroxymethylene)-9-phenyl-3,4-dihydroacridin-1(2H)-one (4) was reacted with 
hydrazine hydrate in ethanol for 2-3h (Scheme. 4), quenched with water and 
recrystallised in ethanol. The crude product obtained was recrystallised by using ethanol 
to give the pure product (5a). The IR spectrum of 5a showed an absorption band at 3385 
cm
-1
 due to the presence of the NH group and two sharp bands at 1625 cm
-1
and1554cm
-
1
assocaited with the presence of the C=N group. The
1
H NMR (CDCl3, 400 MHz) 
spectrum of 5a shows a multiplet at δ 2.610-2.642 due to the C4-CH2 protons, a multiplet 
at δ 3.083-3.267 due to the C5-CH2 protons, a singlet at δ 7.191 due to the C3-H proton 
and the remaining aromatic protons are appeared in the region of δ 7.109-7.867. The13C 
NMR (CDCl3, 100 MHz) spectrum of 5b showed the presence of 20 carbon signals. 
Based on the spectral data, we have assigned the obtained product as 9-Nitro-11-phenyl-
4,5-dihydro-2H-pyrazolo[3,4-a]acridine (5a). The identities of all of the compounds 
(Table. 3) were verified by IR and NMR spectroscopic methods, elemental analysis. The 
structures of pyrazolo[3,4-a]acridine derivatives 5a and 5b were unambiguously 
confirmed by single crystal X-ray diffraction (Fig. 7 & 8). 
 
CONCLUSION 
A simple and efficient method for the synthesis of pyrazolo[3,4-a]acridine derivatives has 
been reported, which does not required high temperatures or harsh conditions. The 
significant features of this reaction are the mild reaction conditions, the operational 
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simplicity, good to high yields, and the use of an inexpensive and commercially available 
reagent. 
EXPERIMENTAL  
Melting points (M.p.) were determined on a Mettler FP 51 apparatus (Mettler 
Instruments, Switzerland) and are uncorrected. They are expressed in degree centigrade 
(°C). A Nicolet Avatar Model FT-IR spectrophotometer was used to record the IR spectra 
(4000–400 cm-1). 1H NMR and 13C NMR spectra were recorded on Bruker AV 400 (400 
MHz (
1
H) and 100 MHz (
13
C)) spectrometers using tetramethylsilane (TMS) as an 
internal reference. The chemical shifts are expressed in parts per million (ppm). Coupling 
constants (J) are reported in hertz (Hz). The terms Jo and Jm refer to ortho coupling 
constant and meta coupling constant. The terms s, d, t, dd refer to singlet, doublet, triplet 
and doublet of doublet, respectively, b s refers to a broad singlet. Microanalyses were 
performed on a Vario EL III model CHNS analyzer (Vario, Germany) at the Department 
of Chemistry, Bharathiar University. Eaton’s reagent was purchased from Sigma Aldrich. 
Unless otherwise specified, other reagents were obtained from commercial suppliers. 
When known compounds had to be prepared according to literature procedures, pertinent 
references are given. The purity of the products was tested by TLC with plates coated 
with silica gel-G using petroleum ether and ethyl acetate in the ratio of 75:25 as 
developing solvents. 
 
GENERAL PROCEDURE FOR SYNTHESIS OF 9-PHENYL-3,4-
DIHYDROACRIDIN-1(2H)-ONES (3): 
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A mixture of an appropriate 2-aminobenzophenone (1, 1 mmol) and 1,3-
cyclohexanedione (2a/2b, 1.2 mmol) was heated for 3h in presence of freshly prepared 
Eaton’s reagent (Phosphorus pentoxide-methanesulfonic acid) as a catalyst without any 
solvent at 90ºC. Then the reaction mass was transferred to an excess saturated sodium 
carbonate solution (30 mL). The solid obtained was filtered and washed with sufficient 
water and extracted with EtOAc (2 × 10 mL) and dried over anhydrous magnesium 
sulphate. Evaporation of the solvent followed by purification on recrystallization from 
ethyl acetate to yield pure 9-phenyl-3,4-dihydroacridin-1(2H)-one (3).  
 
7-Nitro-9-phenyl-3,4-dihydroacridin-1(2H)-one (3a): Yellow solid; M.p. 186-188 ºC 
Yield = 89%; IR (KBr, cm
-1) νmax: 1694; 1552; 
1
H NMR (CDCl3 400 MHz) (ppm) δ: 
2.187-2.251 (m, 2H, C3-CH2), 2.665-2.698 (m, 2H, C2-CH2), 3.334-3.366 (m, 2H, C4-
CH2), 7.109- 7.129 (m, 2H, C3', C5'-H), 7.475-7.490 (m, 3H, C2', C4', C6'-H), 8.112 (d, 
1H, J = 9.20 Hz, C5-H), 8.350 (d, 1H, J = 2.40 Hz, C8-H), 8.435 (dd, 1H, Jm= 2.40 Hz, 
Jo= 9.20 Hz, C6-H); 
13
C NMR (CDCl3, 100 MHz) (ppm) δ: 21.02 (C3), 34.84 (C4), 40.46 
(C2), 124.89 (C13), 125.02 (C10), 125.31 (C6), 126.77 (C2', C6'), 128.05 (C3', C4', C5'), 
128.55 (C8), 130.48 (C5), 135.80 (C1'), 145.53 (C9), 150.45 (C7), 153.21 (C12), 166.15 
(C11), 197.12 (C1); Anal. Calcd. for: C19H14N2O3: C, 71.69; H, 4.43; N, 8.80. Found: C, 
71.66; H, 4.47; N, 8.84%. 
 
GENERAL PROCEDURE FOR SYNTHESIS OF (Z)-2-
(HYDROXYMETHYLENE)-9-PHENYL-3,4-DIHYDROACRIDIN-1(2H)-ONES 
(4):  
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A mixture of an appropriate 9-phenyl-3,4-dihydroacridin-1(2H)-one (3, 1 mmol) and 
ethylformate(1.2 mmol) was added to freshly prepared sodium methoxide (1g sodium in 
10mL methanol) at 0ºC to room temperature for 4-5h. Subsequently the reaction mixture 
was quenched with ice water (45 mL) and extracted with EtOAc (2 × 10 mL) and dried 
over anhydrous magnesium sulphate. Evaporation of the solvent afforded yellow solid 
which was recrystallized from ethyl acetate to give (Z)-2-(hydroxymethylene)-9-phenyl-
3,4-dihydroacridin-1(2H)-one (4). 
 
(Z)-7-Nitro-2-(hydroxymethylene)-9-phenyl-3,4-dihydroacridin-1(2H)-one (4a): 
Brownish yellow solid; M.p. 124-126 ºC Yield = 73%; IR (KBr, cm
-1) νmax: 
3435,1693,1563; 
1
H NMR (CDCl3 400 MHz) (ppm) δ: 2.610-2.642 (m, 2H, C3-CH2), 
3.261-3.291 (m, 2H, C4-CH2), 7.074-7.093 (m, 3H, CHOH, C3', C5'-H), 7.338 (d, 1H, J = 
2.00 Hz, C9-H), 7.428-7.440 (m, 3H, C2', C4', C6'-H), 7.597 (dd, 1H, Jm= 2.00 Hz, Jo= 
8.80 Hz, C6-H), 7.910 (d, 1H, Jo= 8.80 Hz, C5-H), 14.240 (s, 1H, CHOH); 
13
C NMR 
(CDCl3, 100 MHz) (ppm) δ: 29.471 (C3), 34.525 (C4), 113.845 (C2), 122.654 (C13), 
125.463 (C8), 127.783 (C7),128.847 (C4'), 129.336 (C3', C5'), 129.549 (C2', C6'), 130.439 
(C10), 131.467 (C5), 132.352 (C6), 134.023 (C9), 146.312 (C1'), 150.457 (C12), 153.210 
(C11), 166.154 (CHOH), 180.120 (C1); Anal. Calcd. for: C20H14N2O4: C, 69.36; H, 4.07; 
N, 8.09. Found: C, 69.41; H, 4.02; N, 8.13%. 
 
GENERAL PROCEDURE FOR SYNTHESIS OF 11-PHENYL-4,5-DIHYDRO-2H-
PYRAZOLO[3,4-A]ACRIDINES (5):  
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A mixture of an appropriate (Z)-2-(hydroxymethylene)-9-phenyl-3,4-dihydroacridin-
1(2H)-one (4, 1 mmol) and hydrazine hydrate(1.2 mmol) was refluxed in 20mL ethanol 
for 2-3 h. Then the reaction mixture was quenched with water and 1:1HCl afforded 
yellow solid which was recrystallized from ethanol to furnish 11-phenyl-4,5-dihydro-2H-
pyrazolo[3,4-a]acridine(5).  
 
9-Nitro-11-phenyl-4,5-dihydro-2H-pyrazolo[3,4-a]acridine (5a): Brownish yellow solid; 
M.p. 186-188 ºC Yield = 63%; IR (KBr, cm
-1) νmax: 3385, 1625, 1554; 
1
H NMR (CDCl3 
400 MHz) (ppm) δ: 2.610-2.642 (m, 2H, C4-CH2), 3.083-3.267 (m, 2H, C5-CH2), 7.109 
(d, 1H, J = 2.40 Hz, C10-H), 7.191 (s, 1H, C3-H), 7.269-7.323 (m, 2H, C2', C6'-H), 7.399-
7.561 (m, 4H, C3', C4', C5', C8-H), 7.867 (d, 1H, J = 8.80 Hz, C7-H); 
13
C NMR (CDCl3, 
100 MHz) (ppm) δ: 21.27 (C4), 34.08 (C5), 120.45 (C7), 125.84 (C10), 127.27 (C13), 
127.94 (C12), 128.08 (C8), 128.60 (C14), 128.84 (C3', C4', C5'), 129.02 (C2', C6'), 130.21 
(C7), 131.35 (C3), 132.39 (C9), 137.40 (C1'), 145.98 (C11), 146.77 (C16), 152.68 (C15); 
Anal. Calcd. for: C20H14N4O2: C, 70.17; H, 4.12; N, 16.37. Found: C, 70.12; H, 4.17; N, 
16.33%. 
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SUPPLEMENTAL MATERIAL 
Supplemental data for this article can be accessed on the publisher’s website.  Please 
make the words “publisher’s website” a live DOI link.  
Complete CIF files for compounds 3a, 3c, 3f, 4c, 4d, 5c and 5d have been deposited with 
the Cambridge Crystallographic Data Centre as CCDC number 1009510, 984318, 
1047623, 1009511, 1046857, 1019265and 1046856 respectively. Copies of the data can 
be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 
1EZ, UK.[Fax: +44 (0) 1223 336033 or e-mail: deposit@ccdc.cam.ac.uk. 
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Table 1 Synthesis of 3,4-dihydroacridin-1(2H)-one derivatives (3a-f) 
 
Entry R1 R2 R3 Product Yield
a
 
3a. NO2 H H 
 
89% 
3b. NO2 H CH3 
 
90% 
3c. Cl H H 
 
93% 
3d. Cl H CH3 
 
93% 
3e. Cl Cl H 
 
85% 
3f. Cl Cl CH3 
 
87% 
Reaction conditions: 5-chloro-2-aminobenzophenone 1a (1 mmol) and 1,3-cyclohexanedione 2a 
(1.2 mmol, 1.2 equiv.) in the presence of Eaton’s reagent as a catalyst without solvent at 90ºC. 
a
Recrystallised pure products. 
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Table 2 Synthesis of hydroxymethylene derivatives of3,4-dihydroacridin-1(2H)-one (4a-
f) 
Entry R1 R2 R3 Product Yield
a
 
4a. NO2 H H 
 
73% 
4b. NO2 H CH3 
 
70% 
4c. Cl H H 
 
75% 
4d. Cl H CH3 
 
77% 
4e. Cl Cl H 
 
75% 
4f. Cl Cl CH3 
 
73% 
Reaction Conditions: 7-chloro-9-phenyl-3,4-dihydroacridin-1(2H)-one (3a) (1 mmol) and 
ethylformate(1.2 mmol, 1.2 equiv.) in the presence of sodium methoxide at 4-5h in RT. 
a
Recrystallised pure products. 
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Table 3 Synthesis of pyrazolo[3,4-a]acridine derivatives (5a-f) 
Entry R1 R2 R3 Product Yield
a
 
5a. NO2 H H 
 
63% 
5b. NO2 H CH3 
 
60% 
5c. Cl H H 
 
65% 
5d. Cl H CH3 
 
63% 
5e. Cl Cl H 
 
60% 
5f. Cl Cl CH3 
 
62% 
Reaction Conditions: (Z)-7-Chloro-2-(hydroxymethylene)-9-phenyl-3,4-dihydroacridin-1(2H)-one (4a) (1 
mmol) and Hydrazine hydrate (1.2 mmol, 1.2 equiv.) in the presence of ethanol at reflux temperature. 
a
Recrystallised pure products. 
 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
ris
tol
] a
t 0
0:2
8 2
3 J
uly
 20
15
 
  16 
Scheme 1. Synthesis of 7-Nitro-9-phenyl-3,4-dihydroacridin-1(2H)-ones (3a) 
 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
ris
tol
] a
t 0
0:2
8 2
3 J
uly
 20
15
 
  17 
Scheme 2. Synthesis of 3,4-dihydroacridin-1(2H)-ones (3) 
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Scheme 3. Synthesis of Hydroxymethylene derivatives of 3,4-dihydroacridin-1(2H)-ones 
(4) 
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Scheme 4. Synthesis of Pyrazolo[3,4-a]acridine derivatives (5) 
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Figure 1. Pyrazolo[3,4,5,-kl]acridine Scaffold for using clinical trial compounds 
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Figure 2. X-ray crystal structure of 3a, Thermal ellipsoids is depicted at the 50% 
probability level. 
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Figure 3. Room temperature structure of 3c with ellipsoids depicted at the 50% 
probability level.  The material underwent a destructive phase transition upon cooling. 
The structure exhibits disorder in the phenyl ring (C14-C19) and (C8-C13) ring. 
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Figure 4. X-ray structure of 3f with ellipsoids depicted ta the 50% probability level.  
Only one position of the disordered (C14-C19) Cl2 ring has been shown for clarity.<UL> 
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Figure 5. X-ray crystal structure of 4c. Thermal ellipsoids depicted at the 50% 
probability level. 
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Figure 6. X-ray crystal structure of 4d, thermal ellipsoids depicted at 50% probability 
level. 
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Figure 7. X-ray crystal structure of 5c, thermal ellipsoids is depicted at the 50% 
probability level. 
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Figure 8. X-ray crystal structure of 5d, thermal ellipsoids depicted at the 50% probability 
level. 
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